Core Viewpoint - The stock of Shangrong Medical (002551) has experienced a decline, with a closing price of 4.63 yuan on August 22, 2025, down by 1.07% [1] Group 1: Stock Performance and Trading Data - On August 22, 2025, the stock had a turnover rate of 9.98%, with a trading volume of 609,700 hands and a total transaction value of 281 million yuan [1] - The net outflow of main funds was 17.28 million yuan, accounting for 6.15% of the total transaction value, while retail investors saw a net inflow of 27.97 million yuan, representing 9.94% of the total [1][2] - Over the past five days, the stock has shown significant fluctuations, with the highest net outflow of main funds recorded at 64.46 million yuan on August 21, 2025, and a net inflow of retail funds peaking at 67.61 million yuan on the same day [2] Group 2: Financial Metrics and Industry Comparison - Shangrong Medical's total market capitalization is 3.915 billion yuan, with a net asset value of 2.789 billion yuan, and a net profit of 13.9642 million yuan [3] - The company has a price-to-earnings ratio (P/E) of 70.08, which is lower than the industry average of 77.99, while its price-to-book ratio (P/B) stands at 1.48, significantly lower than the industry average of 4.01 [3] - The gross margin of Shangrong Medical is 15.27%, which is considerably below the industry average of 51.31%, indicating potential challenges in profitability [3]
股票行情快报:尚荣医疗(002551)8月22日主力资金净卖出1728.39万元